Published in J Neurooncol on January 01, 1985
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics. Clin Cancer Res (2007) 1.42
Effects of growth factors and basement membrane proteins on the phenotype of U-373 MG glioblastoma cells as determined by the expression of intermediate filament proteins. Am J Pathol (1998) 1.03
Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheral nervous system. Acta Neuropathol (1987) 0.94
Immunohistochemical demonstration of vimentin in human cerebral tumors. Acta Neuropathol (1986) 0.93
Does the pleomorphic xanthoastrocytoma exist? Problems in the application of immunological techniques to the classification of brain tumors. Acta Neuropathol (1988) 0.91
Increased phosphorylation of vimentin in noninfiltrative meningiomas. PLoS One (2010) 0.83
Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas. Am J Pathol (1987) 0.79
Granular cell brain tumors of the laboratory rat: an immunohistochemical approach. Acta Neuropathol (1991) 0.79
Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes. Proc Natl Acad Sci U S A (1993) 0.77
Immunohistochemical observations on rat radial glia: relationship with the origin of ethylnitrosourea-induced tumors. Acta Neuropathol (1992) 0.77
A suprasellar germ cell tumor in a 16-month-old Wagyu heifer calf. J Vet Diagn Invest (2012) 0.75
Glial filaments in the subcutaneous tumors of mouse glioma clones differently expressing glial fibrillary acidic protein. An immunohistochemical and ultrastructural study. Acta Neuropathol (1987) 0.75
Immunochemistry of ethylnitrosourea-induced rat neurinomas, the RN6 neurinoma cell line and their transplantation tumors. Acta Neuropathol (1991) 0.75
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet (1997) 15.38
The somatic genomic landscape of glioblastoma. Cell (2013) 11.73
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol (1999) 8.69
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis (1983) 3.86
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res (1997) 3.38
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene (2000) 2.81
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res (1996) 2.76
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis (1985) 2.64
Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis (1999) 2.28
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol (2000) 2.22
Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res (1987) 2.21
Trichosporon beigelii infection: a review. Rev Infect Dis (1987) 2.15
Systemic candidiasis in cancer patients. Am J Med (1984) 2.05
Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acid. Leuk Lymphoma (1994) 2.04
Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res (1999) 1.95
Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res (1999) 1.88
Klebsiella bacteremia in cancer patients. Am J Med Sci (1973) 1.87
Primary intraorbital meningiomas. Arch Ophthalmol (1974) 1.85
The relationship between the thrombotic and infectious complications of central venous catheters. JAMA (1994) 1.85
Influenza among hospitalized adults with leukemia. Clin Infect Dis (1997) 1.68
Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res (1999) 1.66
Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol (2000) 1.66
Response and progression in recurrent malignant glioma. Neuro Oncol (1999) 1.57
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res (1998) 1.52
Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol (1991) 1.47
Leigh's necrotizing encephalomyelopathy. Neuro-ophthalmological abnormalities. Arch Ophthalmol (1971) 1.46
Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology (1998) 1.46
Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res (1981) 1.44
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Aliment Pharmacol Ther (2006) 1.42
Metastases from testicular carcinoma. Study of 78 autopsied cases. Urology (1976) 1.41
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1995) 1.41
The autocrine loop of TGF-alpha/EGFR and brain tumors. J Neurooncol (1997) 1.40
Aspergillus epiglottitis. Cancer (1983) 1.39
The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care (1997) 1.37
Skin lesions associated with disseminated candidiasis. JAMA (1974) 1.36
Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. J Clin Oncol (2000) 1.35
Secondary renal neoplasms: an autopsy study. South Med J (1979) 1.33
New mutant mouse with communicating hydrocephalus and secondary aqueductal stenosis. Acta Neuropathol (1972) 1.32
Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sci (1970) 1.28
Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo. Cancer Res (1999) 1.28
Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro Oncol (2000) 1.27
Combined therapeutic approach to malignant lacrimal gland tumors. Am J Ophthalmol (1975) 1.26
Causes of death in patients with malignant lymphoma. Am J Med Sci (1974) 1.25
Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res (1996) 1.21
Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer (1995) 1.21
Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis (1996) 1.20
History of tumors of the pineal region. Am J Surg Pathol (1981) 1.20
Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. Eur J Cancer (2000) 1.19
Necrotizing colitis in patients with cancer. Am J Med (1979) 1.19
A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards. Mol Cell Probes (2000) 1.18
Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat Med (1998) 1.18
Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res (1993) 1.15
Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene (2001) 1.14
In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin. Eur J Clin Microbiol (1986) 1.13
An intermediate filament-associated protein, p50, recognized by monoclonal antibodies. J Cell Biol (1983) 1.11
Upper limits on a stochastic background of gravitational waves. Phys Rev Lett (2005) 1.11
The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways. Brain (1982) 1.08
Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2. Cancer Res (2001) 1.07
Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst (1997) 1.07
Kaposi's sarcoma presenting as scrotal ulcerations. Urology (1977) 1.07
The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg (1978) 1.06
Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene (1997) 1.06
The striatonigral degenerations. Putaminal pigments and nosology. Brain (1975) 1.05
Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res (1982) 1.05
Parainfluenza virus infection in adult bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis (1993) 1.04
Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury. Neurosurgery (1984) 1.04
Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer. Am J Clin Oncol (2001) 1.03
Altered expression and distribution of heparan sulfate proteoglycans in human gliomas. Cancer Res (1989) 1.02
Varicella dendritic keratitis. Invest Ophthalmol (1974) 1.02
Clinical trial end points in malignant glioma: need for effective trial design strategy. Semin Oncol (2000) 1.01
Extragonadal germ cell tumors. Surgery (1973) 1.00
Human tissue distribution of platinum after cis-diamminedichloroplatinum. Cancer Chemother Pharmacol (1982) 1.00
Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. J Neurooncol (1997) 0.99
Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol (1993) 0.99
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther (2008) 0.99
The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery (1997) 0.98
Expression of an altered epidermal growth factor receptor by human glioblastoma cells. Cancer Res (1988) 0.98
The separation of pineocytoma from pineoblastoma. Cancer (1980) 0.98
Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro Oncol (2001) 0.98
Fusarium. A newly recognized fungal pathogen in immunosuppressed patients. Cancer (1986) 0.98
Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity. J Interferon Res (1990) 0.98
p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas. Cancer (1996) 0.97
Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway. J Biol Chem (2001) 0.97
Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Clin Cancer Res (2001) 0.97
Disseminated infection due to Mycobacterium avium-intracellulare in a homosexual man with Kaposi's sarcoma. J Infect Dis (1982) 0.96
Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas. Cancer Res (1997) 0.95
Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Clin Cancer Res (2000) 0.95
The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin). J Neurooncol (1997) 0.95
Testicular growth hormone (GH): GH expression in spermatogonia and primary spermatocytes. Gen Comp Endocrinol (2004) 0.95
Imaging patterns of multifocal gliomas. Eur J Radiol (1993) 0.94
The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines. Clin Cancer Res (2000) 0.94
Hemangiomas of the sphenoid sinus. Otolaryngol Head Neck Surg (1979) (1980) 0.94
Nonbacterial thrombotic endocarditis in cancer patients: comparison of characteristics of patients with and without concomitant disseminated intravascular coagulation. Med Pediatr Oncol (1978) 0.94
Cadmium determination in Mexican-produced tobacco. Environ Res (1991) 0.93
Light chain deposition disease derived from the kappa I light chain subgroup. Biochemical characterization. Am J Pathol (1989) 0.93
Recurrent polyneuropathy and neurolymphomatosis. Arch Neurol (1971) 0.93
Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene (1996) 0.93
Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem Photobiol (1991) 0.93
Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades. Clin Exp Metastasis (2000) 0.93
Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis (2001) 0.92